• News
  • Contact
  • Careers
ClairiGene
  • Who We Are
  • Neurodegenerative Diseases
  • Platform
  • Pipeline
Select Page

Dr. Kantor discussed CLAIRIgene’s APOE-targeted epigenome therapy for Alzheimer’s in an interview for VJDementia as part of the journal series for AAIC 2022. 

Aug 2022

Click at the link Developing APOE targeted epigenome therapy for the treatment of Alzheimers Disease to listen to the interview.

Address

701 W. Main St.,
Ste. 200,
Durham, NC 27701

© All rights reserved.